Figure 2: Evaluation of skeletal malformation in fetuses by Alizarin – Red S & Alcian blue double staining of vehicle (Group I) and MSF (Group IIb)-treated female rats at 50 mg /kg b.wt./day; p.o. Note normal skeletal morphology in both groups
|
|
Close |
|
Figure 2: Evaluation of skeletal malformation in fetuses by Alizarin – Red S & Alcian blue double staining of vehicle (Group I) and MSF (Group IIb)-treated female rats at 50 mg /kg b.wt./day; p.o. Note normal skeletal morphology in both groups
|
|